FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to complex of hexamer non-peptide polymer conjugate and insulin with ions of trivalent cobalt, and can be used in medicine. Invention enables to obtain stable hexamer form of insulin, associated with non-peptide polymer with increased life time and preserving function of glucose level control in blood.
EFFECT: obtained complex can be used in pharmaceutical composition for treating diabetes.
15 cl, 4 dwg, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN CONJUGATE WITH APPLICATION OF IMMUNOGLOBULIN FRAGMENT | 2011 |
|
RU2519073C1 |
| LIQUID FORMULATION OF LONG-ACTING INSULIN CONJUGATE | 2013 |
|
RU2670270C2 |
| NOVEL INSULIN ANALOGUE AND USE THEREOF | 2014 |
|
RU2676729C2 |
| SITE-SPECIFIC INSULIN CONJUGATE | 2014 |
|
RU2677800C2 |
| COMPOSITION FOR TREATING DIABETES, CONTAINING LONG-ACTING INSULIN CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | 2012 |
|
RU2606840C2 |
| LIQUID COMPOSITION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE | 2013 |
|
RU2643766C2 |
| POLYPEPTIDE COMPLEX CONTAINING NON-PEPTIDYL POLYMER, HAVING THREE FUNCTIONAL ENDS | 2009 |
|
RU2483081C2 |
| IMPROVED METHOD FOR HIGH-YIELD PRODUCTION OF PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATE | 2014 |
|
RU2677796C9 |
| PHARMACEUTICAL COMPOSITION FOR NON-ALCOHOLIC FATTY LIVER DISEASE PREVENTION OR TREATMENT | 2013 |
|
RU2635966C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY-RELATED DISEASES CONTAINING INSULINOTROPIC PEPTIDE CONJUGATE | 2008 |
|
RU2446816C2 |
